|
Cerebricon to Exhibit at the SFN 39th Annual Meeting in Chicago IL.
September 2nd, 2009 Kuopio, Finland; Wilmington MA, USA
Cerebricon to Exhibit at the SFN 39th Annual Meeting in Chicago IL.
Cerebricon – new member of the Charles River family - will be attending this year’s Society for Neuroscience annual meeting in Chicago. The meeting takes place at the McCormick Place Campus, 2301 S. Lake Shore Drive, Chicago, IL. 60616.
Cerebricon is very proud to announce that they will be exhibiting four posters at this year's congress. Content of the presentations will include:
- Characterization of myelin oligodendrocyte glycoprotein (MOG) and proteolipid protein (PLP) induced experimental autoimmune encephalomyelitis models in mice (244.1/J29, South Hall A , Sunday, Oct 18, 2009, 1:00 PM - 2:00 PM)
- SAN-61 protects against Ab1-42, OGD and H2O2 in rat mixed cortical cultures and inhibits GSK-3b (336.16/L15, South Hall A, Monday, Oct 19, 2009, 11:00 AM -12:00 PM)
- Evaluation of cerebral inflammation and gliosis in Tg2576 mouse model of Alzheimer’s disease (528.17/I12, South Hall A, Tuesday, Oct 20, 2009, 8:00 AM - 9:00 AM)
- GLY515n, a novel EPO-like molecule, promotes functional recovery and reduces the incidence of haemorrhagic transformations in a rat stroke model (639.5/Q12, South Hall A, Tuesday, Oct 20, 2009, 1:00 PM - 2:00 PM)
The meeting runs from Saturday, Oct. 17 - Wednesday, Oct. 21, 2009. Cerebricon will occupy booth number 1817 and will have personnel on-hand in order to answer any questions visitors may have regarding preclinical services and preclinical drug development.
Cerebricon and Charles River wishes a very warm welcome to all visitors and delegates at this year’s SFN meeting in Chicago. For more information please contact Cerebricon at info@cerebricon.com.
|
|
|
|